Journament

Keyword Connections - thyroid cancer Keywords

Connection Type	Connection
Journals	Organic letters Physical chemistry chemical physics : PCCP Environmental science & technology BMC cancer bmj case reports the laryngoscope cancer letters
Research Groups	No Research Group Connected
Bibliographies	[1] Mouse Models of Thyroid Cancer: Bridging Pathogenesis and Novel Therapeutics. [2] Simultaneous presentation of parathyroid carcinoma, papillary thyroid cancer and ACTH-independent hypercortisolism due to benign cortical adenoma. [3] The Usefulness of the Thyroid Imaging Reporting and Data System in Determining Thyroid Malignancy. [4] Evaluation of the expression levels of BRAF mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay. [5] Self-Catalyzed Rapid Synthesis of -Acylated/-Formylated α-Aminoketones and -Hydroxymethylated Formamides from 3-Aryl-2-Azirines and 2-Me/Ph-3-Aryl-2-Azirines. [6] Enrichment of geogenic ammonium in Quaternary alluvial-lacustrine aquifer systems: Evidence from carbon isotopes and DOM characteristics. [7] Twisting and bending photo-excited phenylethynylbenzenes - a theoretical analysis. [8] the evolution of biomarkers in thyroid cancer—from mass screening to a personalized biosignature [9] prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer [10] a rare silent killer: right atrial metastasis of thyroid hürthle cell carcinoma [11] metabolic reprogramming in thyroid carcinoma [12] thyroid cancer in ecuador, a 16 years population-based analysis (2001–2016) [13] epigenetic modifications in thyroid cancer cells restore nis and radio-iodine uptake and promote cell death [14] thyroid cancer in toxic and non-toxic multinodular goiter [15] Targeting mitochondria with Au-Ag@Polydopamine nanoparticles for papillary thyroid cancer therapy. [16] Novel design of NIR-triggered plasmonic nanodots capped mesoporous silica nanoparticles loaded with natural capsaicin to inhibition of metastasis of human papillary thyroid carcinoma B-CPAP cells in thyroid cancer chemo-photothermal therapy. [17] The Role of ATP-Binding Cassette Transporters in the Chemoresistance of Anaplastic Thyroid Cancer: A Systematic Review [18] Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer [19] Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer [20] Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer [21] Unusual Case of Malignant Struma Ovarii and Cervical Thyroid Cancer Preceded by Ovarian Teratoma: Case Report and Review of the Literature [22] Outcome of Cervical Lymph Nodes Dissection for Thyroid Cancer with Nodal Metastases: A Southeast Asian 3-Year Experience [23] Clinical, Pathological and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer. [24] Expression of ANGPTL2 and its impact on papillary thyroid cancer. [25] A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance [26] Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models [27] Detection at Public Facilities of I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. [28] Benchmarking health-related quality of life in thyroid cancer versus other cancers and United States normative data. [29] Mouse Models of Thyroid Cancer: Bridging Pathogenesis and Novel Therapeutics. [30] A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer. [31] Simultaneous presentation of parathyroid carcinoma, papillary thyroid cancer and ACTH-independent hypercortisolism due to benign cortical adenoma. [32] Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A case Report. [33] Locally unresectable differentiated thyroid cancer: outcomes and perspectives. [34] Evaluation of the expression levels of BRAF mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay. [35] p21-Activated Kinases in Thyroid Cancer [36] fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [37] adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer [38] the evolution of biomarkers in thyroid cancer—from mass screening to a personalized biosignature [39] prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer [40] simultaneous presentation of giant pheochromocytoma, primary hyperparathyroidism, and mixed-medullary-papillary thyroid cancer in men 2a [41] comparative clinicopathological and outcome analysis of differentiated thyroid cancer in saudi patients aged below 60 years and above 60 years [42] prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis [43] thyroid cancer in ecuador, a 16 years population-based analysis (2001–2016) [44] current state of diagnosis and treatment of medullary thyroid cancer [45] anaplastic transformation of papillary thyroid cancer in the retroperitoneum [46] update on epidemiology classification, and management of thyroid cancer [47] differences in mirna and mrna profile of papillary thyroid cancer variants [48] short-term side effects after radioiodine treatment in patients with differentiated thyroid cancer [49] radioactive iodine administration is associated with persistent related symptoms in patients with differentiated thyroid cancer [50] neoadjuvant therapy in differentiated thyroid cancer [51] review of factors related to the thyroid cancer epidemic [52] sistema glutation-s-transferase como fator prognóstico no carcinoma papilífero da tireoide gst genes expression as prognostic factor in papillary thyroid cancer [53] role of chemokines in thyroid cancer microenvironment: is cxcl8 the main player? [54] tsh variability of patients affected by differentiated thyroid cancer treated with levothyroxine liquid solution or tablet form [55] new treatment in advanced thyroid cancer [56] epigenetic modifications in thyroid cancer cells restore nis and radio-iodine uptake and promote cell death [57] aggressive multimodal approach for anaplastic thyroid cancer and long-term survival [58] surgical treatment of advanced thyroid cancer invading the trachea, a case presentation and review of literature [59] the role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview [60] resveratrol sensitizes selectively thyroid cancer cell to 131-iodine toxicity [61] thyroid cancer in toxic and non-toxic multinodular goiter [62] patterns of cervical lymph node metastases in primary and recurrent papillary thyroid cancer [63] association of pre-mir-146a rs2910164 polymorphism with papillary thyroid cancer [64] a rare presentation of autonomously functioning papillary thyroid cancer: malignancy in marine-lenhart syndrome nodule [65] on the ret rearrangements in chernobyl-related thyroid cancer [66] Astatine-211: Endogenous Alpha-Radiotherapy for Thyroid Cancer [67] Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments [68] Navigating thyroid cancer: a theranostics odyssey &quot;joining the dots to make a line&quot;